Present Research Molecular Medicine 2018 Conference Focuses on:

Presently Molecular Medicine 2018 mainly concentrates on the Utilization of targeted near-infrared molecular imaging to improve pulmonary metastasectomy of osteosarcomas. Researchers proclaim that targeted fluorescence effectively recognised pulmonary metastases in a patient with osteosarcoma, making it easier for surgeons to locate the tumours for resection. More than 90% of primary lung cancers accumulate OTL38 and generate tumour fluorescence during minimally invasive pulmonary resection, suggesting that this technique may have application beyond pulmonary osteosarcoma.

Future Research: Future research will explore if this approach could be applicable to other pulmonary malignancies that express the FRα.

Keynote Speech:

Hildegund C.J. Ertl

Director, World Health Organization (WHO), Professor
The Wistar Institute
Philadelphia, USA

Title:

“Improving the outcome of T-cell immunotherapy of cancers by pre-conditioning T cell metabolism towards fatty acid catabolism”